Drawing for CELL2SPHERE

USPTO serial 79205802

CELL2SPHERE

Reviewed by CopyMark Law Group

Reg. 5420462Status 709
Filing date
Status date
Registration date
Mar 13, 2018
Examiner
RIEPEL, CHRISTINA MAXINE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CELL2SPHERE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

GORDON E R TROY

GORDON E R TROY Gordon E. R. Troy, PCP.O. Box 67Windsor, VT 05089UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for commercial and scientific purposes, other than for medical or veterinary use; biological tissue cultures, cells and cell culture media, other than for medical or veterinary purposes, namely, for scientific and research use; kits for scientific and research use comprised of biological tissue cultures, cells and cell culture media, not for medical or veterinary purposes; chemicals, reagents, biological tissue cultures, cells and cell culture media for use in relation to drug discovery; chemicals, reagents, biological tissue cultures, cells and cell culture media for use in relation to scientific research; kits for scientific and research use comprised primarily of chemical compounds and culture medium for cell culture analysis and also containing plastic laboratory platesSECTION 71 - CANCELLED—
005Pharmaceuticals, namely, biological tissue cultures and cell cultures for medical or clinical use; pharmaceuticals for use in the fields of oncology and hepatology; pharmaceuticals for the treatment of cancer and hepatic diseases; medical preparations, namely, biological tissue cultures for medical, veterinary and surgical purposes; diagnostic reagents for pharmaceutical, veterinary and medical use; diagnostic preparations for use in the fields of oncology and hepatology for pharmaceutical, veterinary and medical use; diagnostic preparations for the treatment of cancer and hepatic diseases for pharmaceutical, veterinary and medical use; diagnostic biomarker reagents for medical purposes; enzymes for medical and veterinary purposes; biological tissue cultures, living cells, cell culture media for growing cells and stem cells for medical and veterinary purposes; diagnostic cell cultures for medical and veterinary purposesSECTION 71 - CANCELLED—
042Scientific, technological and design services, namely, technical research and design in the field of new pharmaceuticals; scientific research and development; research and development in the field of microorganisms and cells; scientific and technologic services, namely, industrial analysis and research services in the field of biotechnology and pharmaceuticals; scientific research consulting services relating to cell culture research and development in analytical or therapeutic fields; laboratory consulting services relating to the production of artificial biological tissue in analytical or therapeutic fields; scientific research consulting services relating to the use of biological tissue in analytical or therapeutic research fields; contract research services relating to biotechnology; laboratory research in the field of biotechnology and pharmaceuticals; drug discovery services; scientific services, namely, providing laboratory research services relating to the isolation and/or cultivation of human tissues and cells; scientific services, namely, providing laboratory research services relating to the isolation and/or cultivation of human tissues and cells for diagnostic purposesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 24, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Oct 2, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 2, 2025INPCINVALIDATION PROCESSED—
May 27, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 27, 2024C71TCANCELLED SECTION 71—
Mar 13, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 16, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 16, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 16, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 16, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 10, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 26, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 26, 2018FIMPFINAL DISPOSITION PROCESSED—
Jun 13, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 13, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 26, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 26, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 22, 2017GPNXNOTIFICATION PROCESSED BY IB—
Dec 6, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 6, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 6, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 13, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 11, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 10, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 10, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 13, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 13, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 3, 2017RFNTREFUSAL PROCESSED BY IB—
May 12, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 12, 2017RFRRREFUSAL PROCESSED BY MPU—
May 8, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 7, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 2, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 28, 2017DOCKASSIGNED TO EXAMINER—
Apr 28, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 20, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance